Merit Financial Statements From 2010 to 2024

MMSI Stock  USD 105.33  0.30  0.29%   
Merit Medical financial statements provide useful quarterly and yearly information to potential Merit Medical Systems investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Merit Medical financial statements helps investors assess Merit Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Merit Medical's valuation are summarized below:
Gross Profit
519.1 M
Profit Margin
0.0905
Market Capitalization
6.1 B
Enterprise Value Revenue
4.8531
Revenue
1.3 B
We have found one hundred twenty available fundamental ratios for Merit Medical, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of Merit Medical last-minute fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The Merit Medical's current Market Cap is estimated to increase to about 3.8 B. The Merit Medical's current Enterprise Value is estimated to increase to about 4 B

Merit Medical Total Revenue

1.32 Billion

Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 106.4 M, Interest Expense of 16.3 M or Total Revenue of 1.3 B, as well as many indicators such as Price To Sales Ratio of 2.66, Dividend Yield of 0.0 or PTB Ratio of 3.6. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
  
Check out the analysis of Merit Medical Correlation against competitors.

Merit Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.4 B2.3 B1.2 B
Slightly volatile
Short and Long Term Debt Total935.9 M891.4 M354.5 M
Slightly volatile
Other Current Liabilities126.5 M120.4 M71.6 M
Slightly volatile
Total Current Liabilities213.7 M203.6 M131 M
Slightly volatile
Total Stockholder Equity1.3 B1.2 B714.1 M
Slightly volatile
Property Plant And Equipment Net468.9 M446.6 M319.5 M
Slightly volatile
Net Debt317.3 M302.2 M248.3 M
Slightly volatile
Non Current Assets Total1.3 B1.2 B837.8 M
Slightly volatile
Net Receivables198.7 M189.3 M116.3 M
Slightly volatile
Common Stock Shares Outstanding39.5 M58.4 M46.7 M
Slightly volatile
Liabilities And Stockholders Equity2.4 B2.3 B1.2 B
Slightly volatile
Non Current Liabilities Total965.7 M919.7 M393.8 M
Slightly volatile
Inventory319.1 M303.9 M162.9 M
Slightly volatile
Other Current Assets27.5 M26.2 M15.5 M
Slightly volatile
Total Liabilities1.2 B1.1 B524.8 M
Slightly volatile
Property Plant And Equipment Gross814.4 M775.6 M394.6 M
Slightly volatile
Total Current Assets1.2 B1.1 B401.1 M
Slightly volatile
Short Term Debt10.5 M12.1 M16 M
Slightly volatile
Intangible Assets342.2 M325.9 M230.8 M
Slightly volatile
Cash618.6 M589.1 M106.2 M
Slightly volatile
Cash And Short Term Investments618.6 M589.1 M106.2 M
Slightly volatile
Accounts Payable69.2 M65.9 M42.4 M
Slightly volatile
Non Currrent Assets Other33.9 M32.3 M22.5 M
Slightly volatile
Common Stock Total Equity815.3 M776.5 M410.2 M
Slightly volatile
Common Stock670.1 M638.1 M391.3 M
Slightly volatile
Other Liabilities35.4 M60.3 M52.2 M
Slightly volatile
Other Assets25.7 M36.7 M37.7 M
Slightly volatile
Long Term Debt864.2 M823 M317.6 M
Slightly volatile
Good Will401.4 M382.2 M253.5 M
Slightly volatile
Property Plant Equipment462.4 M440.4 M310.5 M
Slightly volatile
Current Deferred Revenue3.9 M4.6 MM
Slightly volatile
Net Tangible Assets614.3 M585 M261 M
Slightly volatile
Long Term Debt Total281.4 M214.8 M237 M
Slightly volatile
Long Term Investments12.1 M19.1 M9.1 M
Slightly volatile
Non Current Liabilities Other15 M15.7 M26.3 M
Slightly volatile
Deferred Long Term Asset Charges1.9 M2.1 M2.2 M
Pretty Stable
Short and Long Term Debt9.4 M10.1 M11 M
Very volatile
Net Invested Capital1.5 BB1.2 B
Slightly volatile
Net Working Capital950.2 M904.9 M319 M
Slightly volatile
Capital Stock681.9 M638.1 M598.2 M
Slightly volatile
Capital Lease Obligations60.7 M68.3 M79.9 M
Slightly volatile

Merit Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization106.4 M101.3 M61.4 M
Slightly volatile
Total Revenue1.3 B1.3 B748.8 M
Slightly volatile
Other Operating Expenses1.2 B1.1 B692.8 M
Slightly volatile
Cost Of Revenue707.2 M673.5 M413.9 M
Slightly volatile
Total Operating Expenses482.9 M459.9 M278.8 M
Slightly volatile
Research Development86.9 M82.7 M50.6 M
Slightly volatile
Selling General Administrative379.2 M361.2 M227.1 M
Slightly volatile
Non Recurring11.7 M10.2 M12.5 M
Slightly volatile
Interest Income958 K656 K2.9 M
Slightly volatile
Reconciled Depreciation97.5 M98 M72.9 M
Slightly volatile

Merit Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow63.6 M60.6 M30.3 M
Slightly volatile
Depreciation106.4 M101.3 M61.5 M
Slightly volatile
Capital Expenditures29.4 M36.7 M46.2 M
Very volatile
Total Cash From Operating Activities152.4 M145.2 M84 M
Slightly volatile
End Period Cash Flow618.6 M589.1 M106.4 M
Slightly volatile
Stock Based Compensation22.4 M21.3 M8.2 M
Slightly volatile
Change To Netincome30.8 M45.7 M39.8 M
Slightly volatile
Issuance Of Capital Stock39.2 M24.8 M136.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.663.47932.7797
Very volatile
PTB Ratio3.63.63963.1687
Pretty Stable
Days Sales Outstanding64.6654.940557.9209
Very volatile
Book Value Per Share21.9120.870613.824
Slightly volatile
Operating Cash Flow Per Share2.652.52031.6242
Slightly volatile
Average PayablesMM4.5 M
Slightly volatile
Stock Based Compensation To Revenue0.01780.0170.0087
Slightly volatile
Capex To Depreciation0.340.36231.391
Slightly volatile
PB Ratio3.63.63963.1687
Pretty Stable
EV To Sales2.843.71973.1157
Very volatile
Inventory Turnover2.192.21642.8445
Slightly volatile
Days Of Inventory On Hand157165134
Slightly volatile
Payables Turnover7.9410.21319.0381
Slightly volatile
Average Inventory15.9 M18 M19.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.04460.06580.0665
Slightly volatile
Capex To Revenue0.02770.02920.089
Slightly volatile
Cash Per Share10.7710.25541.8971
Slightly volatile
POCF Ratio35.7530.139443.7544
Slightly volatile
Capex To Operating Cash Flow0.240.25281.2667
Slightly volatile
Days Payables Outstanding45.035.738346.3701
Slightly volatile
EV To Operating Cash Flow41.6532.221547.0333
Slightly volatile
Intangibles To Total Assets0.160.30450.3609
Pretty Stable
Current Ratio3.385.44532.6935
Slightly volatile
Tangible Book Value Per Share9.08.57534.4563
Slightly volatile
Receivables Turnover5.116.64366.3537
Pretty Stable
Graham Number29.1327.74513.94
Slightly volatile
Shareholders Equity Per Share21.9120.870613.824
Slightly volatile
Debt To Equity0.720.68470.4437
Pretty Stable
Capex Per Share0.50.63720.9619
Slightly volatile
Average Receivables11.9 M14.3 M15.4 M
Slightly volatile
Revenue Per Share22.9221.831914.5545
Slightly volatile
Interest Debt Per Share15.2914.55956.4866
Slightly volatile
Debt To Assets0.370.35390.2504
Pretty Stable
Short Term Coverage Ratios5.615.915.1111
Slightly volatile
Operating Cycle222220192
Slightly volatile
Price Book Value Ratio3.63.63963.1687
Pretty Stable
Days Of Payables Outstanding45.035.738346.3701
Slightly volatile
Price To Operating Cash Flows Ratio35.7530.139443.7544
Slightly volatile
Company Equity Multiplier1.251.93451.6644
Very volatile
Long Term Debt To Capitalization0.430.40640.2819
Slightly volatile
Total Debt To Capitalization0.430.40640.2951
Pretty Stable
Debt Equity Ratio0.720.68470.4437
Pretty Stable
Quick Ratio4.153.95261.7057
Slightly volatile
Dividend Paid And Capex Coverage Ratio4.153.9551.9731
Slightly volatile
Net Income Per E B T0.620.84230.8937
Pretty Stable
Cash Ratio3.042.89410.627
Slightly volatile
Cash Conversion Cycle180184155
Slightly volatile
Operating Cash Flow Sales Ratio0.07420.11540.1025
Pretty Stable
Days Of Inventory Outstanding157165134
Slightly volatile
Days Of Sales Outstanding64.6654.940557.9209
Very volatile
Price To Book Ratio3.63.63963.1687
Pretty Stable
Fixed Asset Turnover3.212.81562.3581
Slightly volatile
Capital Expenditure Coverage Ratio4.153.9551.9731
Slightly volatile
Price Cash Flow Ratio35.7530.139443.7544
Slightly volatile
Debt Ratio0.370.35390.2504
Pretty Stable
Price Sales Ratio2.663.47932.7797
Very volatile
Asset Turnover1.060.54070.6775
Very volatile
Price Fair Value3.63.63963.1687
Pretty Stable

Merit Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.8 B3.6 B2.4 B
Slightly volatile
Enterprise ValueB3.8 BB
Slightly volatile

Merit Fundamental Market Drivers

Forward Price Earnings27.7778
Cash And Short Term Investments589.1 M

Merit Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Merit Medical Financial Statements

Investors use fundamental indicators, such as Merit Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue4.6 M3.9 M
Total Revenue1.3 B1.3 B
Cost Of Revenue673.5 M707.2 M
Stock Based Compensation To Revenue 0.02  0.02 
Research And Ddevelopement To Revenue 0.07  0.04 
Capex To Revenue 0.03  0.03 
Revenue Per Share 21.83  22.92 
Ebit Per Revenue 0.10  0.06 

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Check out the analysis of Merit Medical Correlation against competitors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.091
Earnings Share
2.05
Revenue Per Share
22.847
Quarterly Revenue Growth
0.078
Return On Assets
0.0456
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.